American Heart Journal
Volume 145, Issue 6 , Pages 962-970 , June 2003

High levels of circulating endothelial microparticles in patients with acute coronary syndromes

  • Leon Bernal-Mizrachi, MD

      Affiliations

    • Wallace H Coulter Platelet Laboratory, Divisions of Hematology/Oncology and Cardiology, University of Miami, and the University of Miami School of Medicine, Miami, Fla, USA
    • ,
  • Wenche Jy, PhD

      Affiliations

    • Wallace H Coulter Platelet Laboratory, Divisions of Hematology/Oncology and Cardiology, University of Miami, and the University of Miami School of Medicine, Miami, Fla, USA
    • Corresponding Author InformationReprint requests: Wenche Jy, PhD, University of Miami School of Medicine, 1600 NW 10th Ave, Mail Code R36A, Miami, FL 33136, USA.
    • ,
  • Joaquin J Jimenez, MD

      Affiliations

    • Wallace H Coulter Platelet Laboratory, Divisions of Hematology/Oncology and Cardiology, University of Miami, and the University of Miami School of Medicine, Miami, Fla, USA
    • ,
  • Juan Pastor, MD

      Affiliations

    • Wallace H Coulter Platelet Laboratory, Divisions of Hematology/Oncology and Cardiology, University of Miami, and the University of Miami School of Medicine, Miami, Fla, USA
    • ,
  • Lucia M Mauro

      Affiliations

    • Wallace H Coulter Platelet Laboratory, Divisions of Hematology/Oncology and Cardiology, University of Miami, and the University of Miami School of Medicine, Miami, Fla, USA
    • ,
  • Lawrence L Horstman, BS

      Affiliations

    • Wallace H Coulter Platelet Laboratory, Divisions of Hematology/Oncology and Cardiology, University of Miami, and the University of Miami School of Medicine, Miami, Fla, USA
    • ,
  • Eduardo de Marchena, MD, FACC

      Affiliations

    • Wallace H Coulter Platelet Laboratory, Divisions of Hematology/Oncology and Cardiology, University of Miami, and the University of Miami School of Medicine, Miami, Fla, USA
    • ,
  • Yeon S Ahn, MD

      Affiliations

    • Wallace H Coulter Platelet Laboratory, Divisions of Hematology/Oncology and Cardiology, University of Miami, and the University of Miami School of Medicine, Miami, Fla, USA

Received 12 March 2002 ,Accepted 16 October 2002.

References 

  1. Lusis AJ. Atherosclerosis. Nature. 2000;407:233–241
  2. Libby P. Current concepts in the pathogenesis of the acute coronary syndromes. Circulation. 2001;104:365–372
  3. Libby P, Ridkin PM, Maseri A. Inflammation and atherosclerosis. Circulation. 2002;105:1135–1143
  4. Combes V, Simon AC, Grau GE, et al.  In vitro generation of endothelial microparticles and possible prothrombotic activity in patients with lupus anticoagulant. J Clin Invest. 1999;104:93–102
  5. Jimenez J, Jy W, Mauro L, et al.  Elevated endothelial microparticles in thrombotic thrombocytopenic purpura (TTP) (findings from brain and renal microvascular cell culture and patients with active disease). Br J Haematol. 2001;112:81–90
  6. Mallat Z, Hugel B, Ohan J, et al.  Shed membrane microparticles with procoagulant potential in human atherosclerotic plaques (a role for apoptosis in plaque thrombogenicity). Circulation. 1999;99:348–353
  7. Bernal-Mizrachi L, Jy W, Horstman LL, et al.  Disturbance of endothelium in acute coronary syndromes monitored with flowcytometric assay of endothelial microparticles (EMP). Blood. 2000;96:270a
  8. Mallat Z, Benamer H, Hugel B, et al.  Elevated levels of shed membrane microparticles with procoagulant potential in the peripheral circulating blood of patients with acute coronary symptoms. Circulation. 2000;101:841–843
  9. Minagar A, Jy W, Jimenez J, et al.  Elevated plasma endothelial microparticles in multiple sclerosis. Neurology. 2001;56:1319–1324
  10. Horstman LL, Ahn YS. Platelet microparticles (a wide-angle perspective). Crit Rev Oncol Hematol. 1999;30:111–142
  11. Jy W, Horstman LL, Arce M, et al.  Clinical significance of platelet microparticles in autoimmune thrombocytopenias. J Lab Clin Med. 1992;119:334–345
  12. Gibbons R, Chatterjee K, Daley J, et al.  ACC/AHA/ACP-ASIM guidelines for the management of patients with chronic stable angina (executive summary and recommendations). Circulation. 1999;99:2829–2848
  13. Lindahl B, Toss H, Siegbahn A, et al.  Markers of myocardial damage and inflammation in relation to long-term mortality in unstable coronary artery disease. FRISC Study Group. Fragmin during Instability in Coronary Artery Disease. New Engl J Med. 2000;343:1139–1147
  14. Venge P, Lagerqvist B, Diderholm E, et al.  Clinical performance of three cardiac troponin assays in patients with unstable coronary artery disease (a FRISC II substudy). Am J Cardiol. 2002;89:1035–1041
  15. Morrow DA, Cannon CP, Rifai N, et al.  Ability of minor elevations of troponins I and T to predict benefit from an early invasive strategy in patients with unstable angina and non-ST elevation myocardial infarction (results from a randomized trial). JAMA. 2001;286:2405–2412
  16. Katopodis JN, Kolodny L, Jy W, et al.  Platelet microparticles and calcium homeostasis in acute coronary ischemias. Am J Hematol. 1997;54:95–101
  17. Ware JA, Heistad DD. Platelet-endothelium interactions. New Engl J Med. 1993;328:628–635
  18. Casciola-Rosen L, Rosen A, Petri M, et al.  Surface blebs on apoptotic cells are sites of enhanced procoagulant activity (implications for coagulation events and antigenic spread in systemic lupus erythematosus). Proc Natl Acad Sci USA. 1996;93:1624–1629
  19. Mallat Z, Ohan J, Leseche G, et al.  Colocalization of CPP-32 with apoptotic cells in human atherosclerotic plaques. Circulation. 1997;96:424–428
  20. Sabatier F, Roux V, Anfosso F, et al.  Interaction of endothelial microparticles with monocytic cells in vitro induces tissue factor-dependent procoagulant activity. Hemost Thromb Vasc Biol. 2002;99:3962–3970
  21. Jimenez JJ, Jy W, Mauro LM, et al. Endothelial cells release phenotypically and quantitatively distinct microparticles in activation and apoptosis. Thromb Res 2003 (in press)
  22. Aupeix K, Hugel B, Martin T, et al.  The significance of shed membrane microparticles during programmed cell death in vitro, and in vivo, in HIV-1 infection. J Clin Invest. 1997;99:1546–1554
  23. Arnout J. The pathogensis of the anti-phospholipid syndrome (a hypothesis based on parallelisms with heparin-induced thrombocytopenia). Thromb Haemost. 1996;75:536–541
  24. Karimova A, Pinsky DJ. The endothelial response to oxygen deprivation (biology and clinical implications). Intensive Care Med. 2001;27:19–31
  25. Zund G, Nelson DP, Neufeld EJ, et al.  Hypoxia enhances stimulus-dependent inducation of E-selectin on aortic endothelial cells. Proc Natl Acad Sci USA. 1996;93:7075–7080
  26. Franogiannis NG, Smith CW, Entman ML. The inflammatory response in myocardial infarction. Cardiovasc Res. 2002;53:31–47
  27. Combes V, Simon A, Grau G, et al.  In vitro DUPE use 551. J Clin Invest. 1999;104:93–102
  28. Shaw SK, Perkins BN, Lim YC, et al.  Reduced expression of junctional adhesion molecules and platelet/endothelial cell adhesion molecule-1 (CD31) at human vascular endothelial junctions by cytokines tumor necros factor-alpha plus interferon-gamma does not reduce leukocyte transmigration under flow. Am J Pathol. 2001;159:2281–2291
  29. Taubes G. News focus (does inflammation cut to the heart of the matter?). Science. 2002;296:242–245
  30. Entman ML, Michael L, Rossen RD, et al.  Inflammation in the course of early myocardial ischemia. FASEB J. 1991;5: 2529–qd;j37
  31. Hamilton KK, Hattori R, Esmon CT, et al.  Complement proteins C5b-9 induce vesiculation of the endothelial plasma membrane and expose catalytic surface for assembly of the prothrombinase enzyme complex. J Biol Chem. 1990;265:3809–3814
  32. Xiao Z, Theroux P. Platelet activation with unfractionated heparin at therapeutic concentrations and comparison with a low-molecular-weight heparin and with a direct thrombin inhibitor. Circulation. 1998;97:251–256
  33. Mirow N, Brinkmann T, Minami K, et al.  Low dose systemic heparinization combined with heparin-coated extraqcorporeal circulation (effects related to platelets). J Cardiovasc Surg (Torino). 2001;42:579–585
  34. Kruse-Elliott KT, Chaban K, Grossman JE, et al.  Low molecular weight heparin alters porcine neutrophil responses to platelet activating factor. Shock. 1998;10:98–202
  35. Weiler JM, Edens RE, Linhardt RJ, et al.  Heparin and modified heparin inhibit complement activation in vivo. J Immunol. 1992;148:3210–3215
  36. Ferer-Lopez P, Renesto P, Prevost MC, et al.  Heparin inhibits neutrophil-induced platelet activation via cathepsin G. J Lab Clin Med. 1992;119:231–239
  37. Sandset PM, Abildgaard U, Larsen ML. Heparin induced release of intrinsice coagulation pathway inhibitor (EPI). Thromb Res. 1988;50:803–813
  38. Cadroy Y, Gaspin D, Dupouy D, et al.  Heparin reverses the procoagulant properties of stimulated endothelial cells. Thromb Haemost. 1996;75:190–195
  39. Sogo N, Magid KS, Shaw CA, et al.  Inhibition of human platelet aggregation by nitric oxide donor drugs (relative contribution of cGMP-independent mechanisms). Biochem Biophys Res Commun. 2000;279:412–419
  40. Lam JY, Chesebro JH, Fuster V. Platelets, vasoconstriction, and nitroglycerin during arterial wall injury (a new antithrombotic role for an old drug). Circulation. 1988;78:712–716
  41. Martorana PA, Goebel B, Ruetten H, et al.  Coronary endothelial dysfunction after ischemia and reperfusion in the dog (a functional and morphological investigation). Basic Res Cardiol. 1998;93:257–263
  42. Abrams J. Beneficial actions of nitrates in cardiovascular diseases. Am J Cardiol. 1996;77:31C–37C
  43. Jy W, Mao WW, Horstman LL, et al.  A flow cytometric assay of platelet activation marker P-selectin (CD62p) distinguishes heparin-induced thrombocytopenia (HIT) from HIT-with-thrombosis (HITT). Thromb Haemost. 1999;82:1255–1259
  44. Lee DH, Warkentin TE, Denomme GA, et al.  A diagnostic test for heparin-induced thrombocytopenia (detection of platelet microparticles using flow cytometry). Br J Haemotol. 1996;95:724–731
  45. Warkentin TE. Heparin-induced thrombocytopenia and its treatment. J Thromb Thrombol. 2000;9(1 Suppl):S29–S35
  46. Lazar HL, Bao Y, Rivers S, et al.  High tissue affinity angiotensin-converting enzyme inhibitors improve endothelial function and reduce infarct size. Ann Thorac Surg. 2001;72:548–554
  47. Wang SJ, Ballantyne CM, Sharrett R, et al.  Circulating adhesion molecules VCAM-1, ICAM-1, and E-selectin in carotid atherosclerosis and incident coronary heart disease cases. Circulation. 1997;96:4219–4225

☆ Supported by the Wallace H Coulter Foundation, the Roz and Cal Kovens Research Fund, the Charles and Jane Bosco Research Fund, and the Mary Beth Weiss Research Fund.

PII: S0002-8703(03)00103-0

doi: 10.1016/S0002-8703(03)00103-0

American Heart Journal
Volume 145, Issue 6 , Pages 962-970 , June 2003

Article Tools

* Image Usage & Resolution